Last 11,500 KRW
Change Today +250.00 / 2.22%
Volume 32.0K
083790 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 1:10 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

crystalgenomics inc (083790) Snapshot

Open
11,250
Previous Close
11,250
Day High
11,650
Day Low
11,250
52 Week High
08/4/14 - 19,500
52 Week Low
01/27/14 - 8,950
Market Cap
256.5B
Average Volume 10 Days
50.8K
EPS TTM
-628.00
Shares Outstanding
22.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CRYSTALGENOMICS INC (083790)

Related News

No related news articles were found.

crystalgenomics inc (083790) Related Businessweek News

No Related Businessweek News Found

crystalgenomics inc (083790) Details

CrystalGenomics, Inc., a biopharmaceutical company, operates as a structural chemoproteiomics-based drug discovery and development company in South Korea. Its lead development candidate is NSAID (CG100649), which is a tissue specific anti-inflammatory agent with cardiovascular, gastrointestinal, and renal safety profiles. The company’s drug candidates also include CG200745, a histone deacetylase inhibitor for cancer, which is in Phase I clinical trial; and CG400549, an antibiotic candidate for methicillin resistant staphylococcus aureus and vancomycin resistant staphylococcus aureus that has completed Phase I studies in Europe, as well as is in Phase IIa study in the United States. CrystalGenomics, Inc. is based in Seongnam, South Korea.

crystalgenomics inc (083790) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

crystalgenomics inc (083790) Key Developments

CrystalGenomics, Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014

CrystalGenomics, Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 . Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States.

CrystalGenomics, Inc. Presents at HSBC 2nd Annual Asia Investor Forum ­ London, Jun-09-2014

CrystalGenomics, Inc. Presents at HSBC 2nd Annual Asia Investor Forum ­ London, Jun-09-2014 . Venue: The May Fair Hotel, London, United Kingdom.

CrystalGenomics, Inc., Annual General Meeting, Mar 28, 2014

CrystalGenomics, Inc., Annual General Meeting, Mar 28, 2014., at 09:00 Korea Standard Time. Location: Bundang-gu. Agenda: To approve of 2013 financial statements; to approve some changes in the Articles of Association; to approve appointment of directors; to approve appointment of Auditor; to approve of Directors remuneration; to approve grant of stock options for employees; to approve Board of Directors' resolution; and to consider other references concerning investment decisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
083790:KS 11,500.00 KRW +250.00

083790 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ArQule Inc $1.19 USD -0.01
Array BioPharma Inc $4.86 USD +0.06
Exelixis Inc $1.33 USD -0.02
Infinity Pharmaceuticals Inc $17.73 USD +0.54
Rigel Pharmaceuticals Inc $2.44 USD +0.09
View Industry Companies
 

Industry Analysis

083790

Industry Average

Valuation 083790 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 36.7x
Price/Book 4.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 30.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CRYSTALGENOMICS INC, please visit www.cgxinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.